+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Particle Therapy Market by Therapy Type (Heavy Ion Therapy, Proton Therapy), Components (Beam Transport System Components, Cyclotrons & Synchrotrons Accelerators, Treatment Delivery Systems), System, Application Area, End User - Global Forecast 2025-2030- Product Image
Particle Therapy Market by Therapy Type (Heavy Ion Therapy, Proton Therapy), Components (Beam Transport System Components, Cyclotrons & Synchrotrons Accelerators, Treatment Delivery Systems), System, Application Area, End User - Global Forecast 2025-2030- Product Image
Sale

Particle Therapy Market by Therapy Type (Heavy Ion Therapy, Proton Therapy), Components (Beam Transport System Components, Cyclotrons & Synchrotrons Accelerators, Treatment Delivery Systems), System, Application Area, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674447
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Particle Therapy Market grew from USD 1.07 billion in 2024 to USD 1.16 billion in 2025. It is expected to continue growing at a CAGR of 8.58%, reaching USD 1.76 billion by 2030.

Particle therapy stands at the forefront of cancer treatment innovation, combining precision targeting with advanced physics to deliver life-changing outcomes for patients worldwide. This advanced therapeutic approach leverages charged particle beams instead of conventional radiation, offering distinct advantages in minimizing collateral damage to healthy tissues while maximizing tumor control. The evolution of particle therapy is a testament to the dedication of scientists, engineers, and medical professionals who continuously refine and enhance treatment protocols, ensuring the preservation of functionality and quality of life in patients.

In recent years, rapid advancements in accelerator technologies and imaging techniques have bolstered the efficacy of particle therapy. The increasing adoption of these techniques in clinical practice is driven by a deep understanding of the underlying biological responses and a commitment to evidence-based improvements. Furthermore, strategic collaborations across research institutions, technology manufacturers, and clinical centers have accelerated the translation of research breakthroughs into practical, patient-centric solutions.

This summary explores the exponential growth witnessed in particle therapy, while outlining the pivotal factors behind this revolution. It aims to provide a clear roadmap for decision-makers and industry leaders to navigate the complex yet promising landscape of particle therapy, encapsulating technological innovations, market segmentation, regional trends, key players, and actionable recommendations for further progress.

Transformative Shifts in Particle Therapy Market Dynamics

The particle therapy landscape has undergone transformative shifts that continue to redefine the standards of cancer treatment. Technological breakthroughs, clinical innovations, and progressive regulatory frameworks have catalyzed a paradigm shift from traditional radiation therapies to more advanced and finely controlled particle therapies. Ongoing improvements in beam delivery systems and imaging modalities have paved the way for more precise treatment planning and execution, leading to enhanced clinical outcomes.

Emerging trends include the integration of artificial intelligence and machine learning in treatment planning, which further optimizes the precision of beam targeting and reduces treatment times. Additionally, the development of compact accelerator designs has made this therapeutic approach more accessible to a broader range of healthcare facilities, thus facilitating the expansion of treatment options beyond major metropolitan centers.

The industry is also seeing a surge in strategic partnerships and joint ventures among manufacturers, research entities, and clinical practitioners. These collaborations are not only fostering innovations in treatment methodologies but are also setting new benchmarks in safety protocols, operational efficiency, and overall patient care. The convergence of these factors signals a robust future, wherein particle therapy is poised to significantly alter the global oncology landscape and offer an alternative for cases previously deemed inoperable or resistant to conventional treatments.

Crucial Segmentation Insights Driving Market Growth

The segmentation of the particle therapy market provides critical insights into the driving forces and investment opportunities within the field. At the most fundamental level, market analysis is segmented based on therapy type, distinguishing between heavy ion therapy and proton therapy, each with unique clinical advantages and tailored applications. Further segmentation is derived from the components used in these sophisticated systems. Evaluations are conducted across categories such as beam transport system components, cyclotrons and synchrotrons accelerators, and treatment delivery systems. Within the subset of beam transport system components, there is an even deeper analysis that considers the role of beam monitors, bending magnets, and collimators in ensuring the integrity and accuracy of particle paths.

Moreover, the system categorization differentiates between multi-room systems and single-room systems, highlighting the trade-offs in scalability and cost-effectiveness that come with each configuration. The application area segmentation delves into a variety of cancer types, including breast cancer, head and neck cancer, lung cancer, pediatric cancer, and prostate cancer, demonstrating the broad clinical utility of particle therapy. Additionally, the end-user segmentation examines the adoption patterns among hospitals, research institutions, and specialty clinics. Within the hospital segment, the analysis distinguishes between private and public hospitals, while in specialty clinics, further delineation occurs between oncology clinics and radiotherapy centers. This nuanced segmentation highlights the diverse drivers behind market demand and underscores the need for tailored strategies to address the distinct requirements of each segment.

Based on Therapy Type, market is studied across Heavy Ion Therapy and Proton Therapy.

Based on Components, market is studied across Beam Transport System Components, Cyclotrons & Synchrotrons Accelerators, and Treatment Delivery Systems. The Beam Transport System Components is further studied across Beam Monitor, Bending Magnets, and Collimators.

Based on System, market is studied across Multi-Room Systems and Single-Room Systems.

Based on Application Area, market is studied across Breast Cancer, Head And Neck Cancer, Lung Cancer, Pediatric Cancer, and Prostate Cancer.

Based on End User, market is studied across Hospitals, Research Institutions, and Specialty Clinics. The Hospitals is further studied across Private Hospitals and Public Hospitals. The Specialty Clinics is further studied across Oncology Clinics and Radiotherapy Centers.

Regional Trends Shaping the Future of Particle Therapy

Regional insights highlight unique growth trends and market opportunities across various global landscapes. In the Americas, a well-established healthcare infrastructure coupled with robust investment in advanced medical technologies underpins a significant demand for particle therapy solutions. Simultaneously, the region benefits from the convergence of innovative research and a proactive regulatory environment that supports cutting-edge clinical trials and expansive therapy adoption.

Europe, Middle East & Africa exhibit a blend of mature markets and emerging opportunities. In these regions, progressive healthcare policies along with initiatives aimed at reducing the burden of complex cancers encourage the integration of particle therapy into national oncological treatment guidelines. The region’s focus on clinical excellence and technology-driven patient care further fuels the adoption of these innovative therapies. In the Asia-Pacific area, increasing investments in healthcare infrastructure, a growing middle class, and amplified awareness of advanced treatment options translate into a rapid growth trajectory. The region has shown exceptional dynamism in embracing novel technologies, which is supported by government-backed initiatives to modernize healthcare systems and improve patient outcomes through cutting-edge therapeutic options.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Companies Driving Technological Advancements in Particle Therapy

Key companies in the particle therapy sector have established themselves as pivotal players in translating advanced scientific research into high-impact clinical applications. In this competitive landscape, organizations such as B dot Medical Inc. and C-Rad AB are recognized for their pioneering work in developing and refining beam delivery technologies that have redefined clinical treatment precision. Elekta AB and Hitachi, Ltd. have a prominent presence, fostering innovation through strategic technological integrations and global market advocacy. Ion Beam Applications S.A and Koninklijke Philips N.V. have enhanced their market stature through a commitment to research excellence and robust product portfolios that span the gamut of diagnostic and therapeutic tools.

Notably, Leybold by Atlas Copco Group and Mevion Medical Systems have contributed significantly with breakthrough accelerator technologies that improve both operational efficiencies and patient outcomes. Enterprises such as Optivus Proton Therapy, Inc., P-Cure Ltd, and ProTom International Holding Corporation serve as catalysts for technological innovation, specializing in bespoke systems that cater to diverse clinical needs. Provision Healthcare, LLC and PTW Freiburg GmbH focus on the precision calibration of equipment, ensuring that treatment delivery meets the highest standards of safety and effectiveness. Companies such as SAH Global LLC, Shanghai APACTRON Particle Equipment Co., Ltd., and Shinva Medical Instrument Co., Ltd. emphasize localized deployment and support, which is crucial in tailoring solutions to region-specific demands. Global leaders like Siemens Healthineers AG and Stantec Inc. drive integrated solutions that combine engineering prowess with clinical insights, further supported by contributions from Sumitomo Heavy Industries, Ltd., Sun Nuclear Corporation by Mirion Technologies, Toshiba Corporation, and Xstrahl Ltd. Each of these companies plays a critical role in shaping an industry that is as dynamic as it is innovative, bridging the gap between state-of-the-art technology and holistic patient care.

The report delves into recent significant developments in the Particle Therapy Market, highlighting leading vendors and their innovative profiles. These include B dot Medical Inc., C-Rad AB, Elekta AB, Hitachi, Ltd., Ion Beam Applications S.A, Koninklijke Philips N.V., Leybold by Atlas Copco Group, Mevion Medical Systems, Optivus Proton Therapy, Inc., P-Cure Ltd, ProTom International Holding Corporation, Provision Healthcare, LLC, PTW Freiburg GmbH, SAH Global LLC, Shanghai APACTRON Particle Equipment Co., Ltd., Shinva Medical Instrument Co., Ltd., Siemens Healthineers AG, Stantec Inc., Sumitomo Heavy Industries, Ltd., Sun Nuclear Corporation by Mirion Technologies, Toshiba Corporation, and Xstrahl Ltd..

Actionable Recommendations for Sustained Growth and Innovation

For industry leaders seeking to sustain growth and drive innovation within the particle therapy space, a series of actionable recommendations can serve as a blueprint for success. It is imperative to invest in research and development to stay abreast of emerging technologies and refine treatment protocols in line with the latest scientific advancements. Collaborative partnerships with research institutions and technology providers can accelerate the pace of innovation, ensuring that upcoming product iterations not only meet but exceed clinical expectations.

Emphasizing a patient-centric approach by integrating feedback from clinical practitioners and refining end-to-end treatment systems will enhance the value proposition of particle therapy solutions. Leaders should consider optimizing their operational frameworks through the adoption of integrated digital platforms that streamline workflow from diagnosis to treatment delivery. Additionally, expanding market presence by targeting both mature and emerging markets will provide a competitive edge in a dynamically evolving ecosystem.

Furthermore, building expertise in regulatory compliance and quality control is essential to maintaining the highest safety standards. By leveraging data analytics and real-world evidence, organizations can better predict market trends and tailor their strategies to evolving patient needs. Overall, these strategic initiatives not only foster technological excellence but also build a resilient foundation that can adapt to the rapidly changing dynamics of the healthcare landscape.

Executive Summary Conclusion: Forward-Thinking Perspectives and Future Opportunities

In conclusion, particle therapy represents a transformative era in cancer treatment, marked by its precise targeting capabilities, continuous technological innovations, and ever-expanding applications in clinical settings. The evolution of this domain is underscored by a comprehensive segmentation approach that takes into account therapy types, system configurations, and various end-user demands. By integrating insights drawn from market segmentation, regional trends, and the contributions of numerous pioneering companies, the industry is poised to deliver solutions that not only push the boundaries of current medical practices but also create a tangible impact on patient outcomes.

This synthesis of innovation, segmentation precision, and global regional insights establishes a compelling narrative - one that calls for decisive action and continuous improvement. The market is ripe with opportunities for both established players and new entrants who are prepared to invest in research, capitalize on market trends, and foster deep integrations between technology and clinical practice. As we stand on the cusp of this exciting transition in healthcare, the forward-thinking strategies implemented today are set to define the therapeutic paradigms of tomorrow. Ultimately, the continued evolution of particle therapy will play an instrumental role in transforming cancer care on a global scale.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of cancer worldwide with the need for advanced treatment options
5.1.1.2. Growing penetration of proton therapy for targeted cancer care
5.1.1.3. Government initiatives and favorable reimbursement policies encouraging adoption of particle therapy
5.1.2. Restraints
5.1.2.1. High initial investment and limited availability of particle therapy centers
5.1.3. Opportunities
5.1.3.1. Technological advancements in particle therapy are making treatments more efficient and precise
5.1.3.2. Ongoing collaboration with medical technology manufacturer for development of advanced particle therapy
5.1.4. Challenges
5.1.4.1. Stringent regulatory requirements and product recall concerns associated with particle therapy
5.2. Market Segmentation Analysis
5.2.1. Therapy Type: Growing significance of proton therapy in reducing the risk of collateral damage
5.2.2. Components: Preference for precision beam monitoring to enhancing accuracy and safety in particle therapy
5.2.3. System: Increasing adoption of single-room systems to introduce advanced particle therapy
5.2.4. Application Area: Rising application of particle therapy in prostate cancer due to its ability to deliver high doses directly to tumors
5.2.5. End User: Utilization of particle therapy in research institutions for conducting pivotal studies and clinical trials
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Particle Therapy Market, by Therapy Type
6.1. Introduction
6.2. Heavy Ion Therapy
6.3. Proton Therapy
7. Particle Therapy Market, by Components
7.1. Introduction
7.2. Beam Transport System Components
7.2.1. Beam Monitor
7.2.2. Bending Magnets
7.2.3. Collimators
7.3. Cyclotrons & Synchrotrons Accelerators
7.4. Treatment Delivery Systems
8. Particle Therapy Market, by System
8.1. Introduction
8.2. Multi-Room Systems
8.3. Single-Room Systems
9. Particle Therapy Market, by Application Area
9.1. Introduction
9.2. Breast Cancer
9.3. Head And Neck Cancer
9.4. Lung Cancer
9.5. Pediatric Cancer
9.6. Prostate Cancer
10. Particle Therapy Market, by End User
10.1. Introduction
10.2. Hospitals
10.2.1. Private Hospitals
10.2.2. Public Hospitals
10.3. Research Institutions
10.4. Specialty Clinics
10.4.1. Oncology Clinics
10.4.2. Radiotherapy Centers
11. Americas Particle Therapy Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Particle Therapy Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Particle Therapy Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Scenario Analysis
14.3.1. Moffitt Cancer Center invests in ProteusONE proton therapy system to advance precision cancer treatments
14.3.2. Mevion delivers its first MEVION S250-FIT Proton Therapy System to Stanford Health Care
14.3.3. AIG Hospitals’ INR 800 crore investment creates Hyderabad’s first proton therapy centre by acquiring Belgium’s IBA's Proteus ONE system
14.3.4. Duke Health secures transformative USD 50 million donation to launch a USD 120 million proton beam therapy center
14.3.5. ProTom International introduces Radiance 330-C to enhance proton therapy solution
14.3.6. UC Regents approve UCSF proton therapy center for cancer care
14.3.7. Leo Cancer Care and TibaRay join forces to enhance photon therapy
14.3.8. AstraZeneca has entered a definitive agreement to acquire Fusion Pharmaceuticals
14.3.9. WestCan Proton Therapy Inc. invests approximately USD 120 million proton therapy centre fuels cancer care innovation in Edmonton
14.3.10. OncoRay unveils the world’s first whole-body MRI-guided proton therapy system
14.4. Strategy Analysis & Recommendation
14.4.1. ProTom International Holding Corporation
14.4.2. Toshiba Corporation
14.4.3. Ion Beam Applications S.A
14.4.4. Sumitomo Heavy Industries, Ltd.
List of Figures
FIGURE 1. PARTICLE THERAPY MARKET MULTI-CURRENCY
FIGURE 2. PARTICLE THERAPY MARKET MULTI-LANGUAGE
FIGURE 3. PARTICLE THERAPY MARKET RESEARCH PROCESS
FIGURE 4. PARTICLE THERAPY MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 9. GLOBAL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2024 VS 2030 (%)
FIGURE 11. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2024 VS 2030 (%)
FIGURE 13. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2024 VS 2030 (%)
FIGURE 15. GLOBAL PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL PARTICLE THERAPY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 17. GLOBAL PARTICLE THERAPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 19. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 21. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 26. PARTICLE THERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 27. PARTICLE THERAPY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. PARTICLE THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. PARTICLE THERAPY MARKET DYNAMICS
TABLE 7. GLOBAL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAVY ION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROTON THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BEAM MONITOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BENDING MAGNETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COLLIMATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CYCLOTRONS & SYNCHROTRONS ACCELERATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PARTICLE THERAPY MARKET SIZE, BY TREATMENT DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PARTICLE THERAPY MARKET SIZE, BY MULTI-ROOM SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SINGLE-ROOM SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAD AND NECK CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PARTICLE THERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PEDIATRIC CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL PARTICLE THERAPY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL PARTICLE THERAPY MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL PARTICLE THERAPY MARKET SIZE, BY RADIOTHERAPY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 62. CANADA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 63. CANADA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 64. CANADA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 65. CANADA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 66. CANADA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 67. CANADA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. CANADA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 69. CANADA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 70. MEXICO PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 71. MEXICO PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 72. MEXICO PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 73. MEXICO PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 74. MEXICO PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 75. MEXICO PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. MEXICO PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 77. MEXICO PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 96. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 97. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 98. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 104. CHINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 105. CHINA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 106. CHINA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 107. CHINA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 108. CHINA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 109. CHINA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. CHINA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 111. CHINA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 112. INDIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 113. INDIA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 114. INDIA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 115. INDIA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 116. INDIA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 117. INDIA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. INDIA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 119. INDIA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 120. INDONESIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 121. INDONESIA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 122. INDONESIA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 123. INDONESIA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 124. INDONESIA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 125. INDONESIA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. INDONESIA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 127. INDONESIA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 128. JAPAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 129. JAPAN PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 130. JAPAN PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 131. JAPAN PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 132. JAPAN PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 133. JAPAN PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. JAPAN PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 135. JAPAN PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 136. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 137. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 138. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 139. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 140. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 141. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 143. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 144. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 145. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 146. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 147. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 148. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 149. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 151. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 152. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 153. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 154. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 155. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 156. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 157. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 159. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 160. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 162. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 163. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 164. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 165. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 167. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 168. TAIWAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 169. TAIWAN PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 170. TAIWAN PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 171. TAIWAN PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 172. TAIWAN PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 173. TAIWAN PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. TAIWAN PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 175. TAIWAN PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 176. THAILAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 177. THAILAND PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 178. THAILAND PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 179. THAILAND PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 180. THAILAND PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 181. THAILAND PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. THAILAND PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 183. THAILAND PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 184. VIETNAM PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 185. VIETNAM PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 186. VIETNAM PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 187. VIETNAM PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 188. VIETNAM PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 189. VIETNAM PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. VIETNAM PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 191. VIETNAM PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 201. DENMARK PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 202. DENMARK PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 203. DENMARK PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 204. DENMARK PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 205. DENMARK PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 206. DENMARK PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. DENMARK PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 208. DENMARK PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 209. EGYPT PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 210. EGYPT PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 211. EGYPT PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 212. EGYPT PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 213. EGYPT PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 214. EGYPT PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. EGYPT PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 216. EGYPT PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 217. FINLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 218. FINLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 219. FINLAND PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 220. FINLAND PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 221. FINLAND PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 222. FINLAND PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. FINLAND PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 224. FINLAND PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 225. FRANCE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 226. FRANCE PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 227. FRANCE PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 228. FRANCE PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 229. FRANCE PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 230. FRANCE PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. FRANCE PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 232. FRANCE PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 233. GERMANY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 234. GERMANY PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 235. GERMANY PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 236. GERMANY PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 237. GERMANY PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 238. GERMANY PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. GERMANY PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 240. GERMANY PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 243. ISRAEL PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 244. ISRAEL PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 248. ISRAEL PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 249. ITALY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 250. ITALY PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 251. ITALY PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 252. ITALY PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 253. ITALY PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 254. ITALY PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. ITALY PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 256. ITALY PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 257. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 272. NIGERIA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 273. NORWAY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 274. NORWAY PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 275. NORWAY PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 276. NORWAY PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 277. NORWAY PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 278. NORWAY PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. NORWAY PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 280. NORWAY PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 281. POLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 282. POLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 283. POLAND PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 284. POLAND PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 285. POLAND PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 286. POLAND PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. POLAND PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 288. POLAND PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 289. QATAR PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 290. QATAR PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 291. QATAR PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 292. QATAR PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 293. QATAR PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 294. QATAR PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. QATAR PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 296. QATAR PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 297. RUSSIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 298. RUSSIA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 299. RUSSIA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 300. RUSSIA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 301. RUSSIA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 302. RUSSIA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. RUSSIA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 304. RUSSIA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 306. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 308. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 310. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 312. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 314. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 316. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 318. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 320. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 321. SPAIN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 322. SPAIN PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 323. SPAIN PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 324. SPAIN PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 325. SPAIN PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 326. SPAIN PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 327. SPAIN PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 328. SPAIN PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 329. SWEDEN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 330. SWEDEN PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 331. SWEDEN PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 332. SWEDEN PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 333. SWEDEN PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 334. SWEDEN PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 335. SWEDEN PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 336. SWEDEN PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 337. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 338. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 339. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 340. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 341. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 342. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 343. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 344. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 345. TURKEY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 346. TURKEY PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 347. TURKEY PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 348. TURKEY PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 349. TURKEY PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 350. TURKEY PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 351. TURKEY PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 352. TURKEY PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 353. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY THERA

Companies Mentioned

  • B dot Medical Inc.
  • C-Rad AB
  • Elekta AB
  • Hitachi, Ltd.
  • Ion Beam Applications S.A
  • Koninklijke Philips N.V.
  • Leybold by Atlas Copco Group
  • Mevion Medical Systems
  • Optivus Proton Therapy, Inc.
  • P-Cure Ltd
  • ProTom International Holding Corporation
  • Provision Healthcare, LLC
  • PTW Freiburg GmbH
  • SAH Global LLC
  • Shanghai APACTRON Particle Equipment Co., Ltd.
  • Shinva Medical Instrument Co., Ltd.
  • Siemens Healthineers AG
  • Stantec Inc.
  • Sumitomo Heavy Industries, Ltd.
  • Sun Nuclear Corporation by Mirion Technologies
  • Toshiba Corporation
  • Xstrahl Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages184
PublishedMarch 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.16 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.76 Billion
Compound Annual Growth Rate8.5%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Particle Therapy Market Size, Share & Trends Analysis Report by Therapy Type (Proton Therapy, Heavy Ion Therapy), System, Application (Treatment, Research), Cancer Type (Pediatric, Breast, Lung), Region, and Segment Forecasts, 2024-2030 - Product Image

Particle Therapy Market Size, Share & Trends Analysis Report by Therapy Type (Proton Therapy, Heavy Ion Therapy), System, Application (Treatment, Research), Cancer Type (Pediatric, Breast, Lung), Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • Global
From
Particle Therapy - Global Strategic Business Report - Product Image

Particle Therapy - Global Strategic Business Report

  • Report
  • 83 Pages
  • Global
From
Particle Therapy Market Report 2025 - Product Image

Particle Therapy Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Particle Therapy Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Particle Therapy Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 151 Pages
  • Global
From
Particle Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Particle Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 184 Pages
  • Global
From

About the Market

Particle therapy is a type of radiation therapy used to treat cancer. It uses beams of protons or other particles to deliver a precise dose of radiation to the tumor, minimizing damage to surrounding healthy tissue. This type of therapy is particularly useful for treating tumors located near sensitive organs, such as the brain, spinal cord, and eyes. It is also used to treat tumors that are difficult to reach with traditional radiation therapy. Particle therapy is becoming increasingly popular in the oncology drugs market, as it offers a more targeted approach to treating cancer. It is also associated with fewer side effects than traditional radiation therapy, making it a more attractive option for patients. Some of the companies in the particle therapy market include Varian Medical Systems, Elekta, IBA, Hitachi, and ProTom International. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.